Tunneled peritoneal catheter for the management of refractory ascites in a patient with nephrotic
PDF (Español)
xml (Español)


Peritoneal dialysis
tunnelled peritoneal catheter
nephrotic syndrome
refractory ascites
treatment efficacy

How to Cite

Porta-Bisares I, Palacios-Guillen AM, Hernández-Obando E. Tunneled peritoneal catheter for the management of refractory ascites in a patient with nephrotic. Rev. Colomb. Nefrol. [Internet]. 2023 Nov. 24 [cited 2024 Feb. 26];10(3). Available from: https://revistanefrologia.org/index.php/rcn/article/view/719


Introduction: Refractory ascites can be a frequent complication in nephrotic syndrome (NS), there are reported cases of the use of a tunneled peritoneal dialysis catheter in patients with cirrhosis or abdominal neoplasms. The case of a patient with NS is presented in whom used a peritoneal dialysis (PD) catheter to manage refractory ascites.

Purpose: To show that the peritoneal catheter can be considered as an alternative for the management of refractory ascites in patients with nephrotic syndrome.

Presentation of the case: A 19-year-old male patient, with no pathological history, presented progressive edema and impaired renal function. Nephrotic syndrome with anasarca was evidenced, and it evolved with worsening renal function, entering supportive hemodialysis. Renal biopsy was performed: podocytopathy, collapsing glomerulopathy. Corticosteroid treatment was started, improving renal function until hemodialysis was discontinued, but he presented ascites refractory to medical treatment, for which evacuatory paracentesis was performed repeatedly. It was decided to place a tunneled peritoneal catheter for the management of refractory ascites. Ascites gradually decreased until the peritoneal catheter was removed.

Discussion and conclusion: The use of a tunneled peritoneal dialysis catheter is an effective management option in cases of nephrotic syndrome with refractory ascites.

PDF (Español)
xml (Español)


Lewis DM, Tooke JE, Beaman M, Gamble J, Shore AC. Peripheral microvascular parameters in the nephrotic syndrome. Kidney Int. 1998 Oct;54(4):1261-6.


Politano SA, Colbert GB, Hamiduzzaman N. Nephrotic Syndrome. Prim Care. 2020 Dec;47(4):597-613. https://doi.org/10.1016/j.pop.2020.08.002

Udwan K, Brideau G, Fila M, Edwards A, Vogt B, Doucet A. Oxidative stress and nuclear factor ?B (NF-?B) Increase peritoneal filtration and contribute to ascites formation in nephrotic syndrome. J Biol Chem. 2016 May 20;291(21):11105-13.


Carrier P, Jacques J, Debette-Gratien M, Legros R, Sarabi M, Vidal E, et al. L'ascite non liée à la cirrhose: physiopathologie, diagnostic et étiologies. Rev Med Interne. 2014 Jun;35(6):365-71. https://doi.org/10.1016/j.revmed.2013.12.001

Wong F. Management of refractory ascites. Clin Mol Hepatol. 2023 Jan;29(1):16-32. https://doi.org/10.3350/cmh.2022.0104

Knight J., Thompson S., Fleming C., Bendel E., Neisen M., Neidert N., et al. Safety and effectiveness of palliative tunneled peritoneal drainage catheters in the management of refractory malignant and non-malignant ascites. Cardiovasc Intervent Radiol. 2018 May;41(5):753-761. https://doi.org/10.1007/s00270-017-1872-1

Macken L., Hashim A., Mason L., Verma S. Permanent indwelling peritoneal catheters for palliation of refractory ascites in end-stage liver disease: A systematic review. Liver Int. 2019 Sep;39(9):1594-1607. https://doi.org/10.1111/liv.14162

Plancarte R., Guillén M. R., Guajardo J., Mayer F. Ascitis en los pacientes oncológicos: Fisiopatogenia y opciones de tratamiento. Rev. Soc. Esp. Dolor. 2004 Abr;11(3):156-162. https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1134-80462004000300006

Eskander RN, Tewari KS. Emerging treatment options for management of malignant ascites in patients with ovarian cancer. Int J Womens Health. 2012;4:395-404.


Román R. Ascitis. Acta méd. Peruana. 2007 Ene; 24(1):34-39. https://pesquisa.bvsalud.org/gim/resource/fr/lil-692273

De Gottardi A, Thévenot T, Spahr L, Morard I, Bresson-Hadni S, Torres F, et al. A. Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study. Clin Gastroenterol Hepatol. 2009 Aug;7(8):906-9. https://doi.org/10.1016/j.cgh.2009.05.004

Caldwell J, Edriss H, Nugent K. Chronic peritoneal indwelling catheters for the management of malignant and nonmalignant ascites. Proc (Bayl Univ Med Cent). 2018 Jun 1;31(3):297-302.


Lungren M., Kim C., Stewart J., Smith T., Miller M. Tunneled peritoneal drainage catheter placement for refractory ascites: single-center experience in 188 patients. J Vasc Interv Radiol. 2013 Sep;24(9):1303-8. https://doi.org/10.1016/j.jvir.2013.05.042

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.




Download data is not yet available.